These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20629223)

  • 41. [Endothelial dysfunction in type 1 diabetes].
    Bertoluci MC; Cé GV; da Silva AM; Puñales MK
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):416-26. PubMed ID: 18438553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications.
    Domingueti CP; Dusse LM; Carvalho Md; de Sousa LP; Gomes KB; Fernandes AP
    J Diabetes Complications; 2016; 30(4):738-45. PubMed ID: 26781070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Physical activity and endothelial dysfunction in type 2 diabetic patients: the role of nitric oxide and oxidative stress].
    Brinkmann C; Schwinger RH; Brixius K
    Wien Med Wochenschr; 2011 Jun; 161(11-12):305-14. PubMed ID: 21360292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenesis of hypertension in diabetes.
    Stas SN; El-Atat FA; Sowers JR
    Rev Endocr Metab Disord; 2004 Aug; 5(3):221-5. PubMed ID: 15211093
    [No Abstract]   [Full Text] [Related]  

  • 45. Nitric oxide: from basic research on isolated blood vessels to clinical relevance in diabetes.
    Furchgott RF
    An R Acad Nac Med (Madr); 1998; 115(2):317-31. PubMed ID: 9882827
    [No Abstract]   [Full Text] [Related]  

  • 46. TNF-alpha induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone.
    Martens FM; Rabelink TJ; op 't Roodt J; de Koning EJ; Visseren FL
    Eur Heart J; 2006 Jul; 27(13):1605-9. PubMed ID: 16762982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
    Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin-dependent diabetes mellitus and nitrovasodilation. Important and complex interactions.
    Steinberg HO; Baron AD
    Circulation; 1997 Feb; 95(3):560-1. PubMed ID: 9024137
    [No Abstract]   [Full Text] [Related]  

  • 49. Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets.
    Plutzky J; Viberti G; Haffner S
    J Diabetes Complications; 2002; 16(6):401-15. PubMed ID: 12477625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 51. Catechin averts experimental diabetes mellitus-induced vascular endothelial structural and functional abnormalities.
    Bhardwaj P; Khanna D; Balakumar P
    Cardiovasc Toxicol; 2014 Mar; 14(1):41-51. PubMed ID: 24048981
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular mechanisms linking diabetes to the accelerated development of atherosclerosis.
    Zeadin MG; Petlura CI; Werstuck GH
    Can J Diabetes; 2013 Oct; 37(5):345-50. PubMed ID: 24500563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal perfusion and the renal hemodynamic response to blocking the renin system in diabetes: are the forces leading to vasodilation and vasoconstriction linked?
    Lansang MC; Hollenberg NK
    Diabetes; 2002 Jul; 51(7):2025-8. PubMed ID: 12086929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies.
    Rangel ÉB; Rodrigues CO; de Sá JR
    J Diabetes Res; 2019; 2019():2161085. PubMed ID: 30911551
    [No Abstract]   [Full Text] [Related]  

  • 55. [Possible involvement of insulin and oxidative stress in vascular dysfunction of diabetic mellitus].
    Kobayashi T
    Yakugaku Zasshi; 2008 Jul; 128(7):1013-21. PubMed ID: 18591869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial dysfunction, inflammation and diabetes.
    Dandona P; Aljada A; Chaudhuri A; Mohanty P
    Rev Endocr Metab Disord; 2004 Aug; 5(3):189-97. PubMed ID: 15211090
    [No Abstract]   [Full Text] [Related]  

  • 57. Endothelial function and the prediction of CVD in diabetes.
    Bugiardini R
    Curr Diab Rep; 2006 Feb; 6(1):17-21. PubMed ID: 16522276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular compliance in diabetes.
    Winer N; Sowers JR
    Curr Diab Rep; 2003 Jun; 3(3):230-4. PubMed ID: 12762971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes and the maternal resistance vasculature.
    Ang C; Lumsden MA
    Clin Sci (Lond); 2001 Dec; 101(6):719-29. PubMed ID: 11724662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glaxo/MRS Young Investigator Prize. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus.
    Poston L; Taylor PD
    Clin Sci (Lond); 1995 Mar; 88(3):245-55. PubMed ID: 7736692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.